Page last updated: 2024-10-19

phosphoenolpyruvate and Left Ventricular Hypertrophy

phosphoenolpyruvate has been researched along with Left Ventricular Hypertrophy in 1 studies

Phosphoenolpyruvate: A monocarboxylic acid anion derived from selective deprotonation of the carboxy group of phosphoenolpyruvic acid. It is a metabolic intermediate in GLYCOLYSIS; GLUCONEOGENESIS; and other pathways.
phosphoenolpyruvate : A monocarboxylic acid anion resuting from selective deprotonation of the carboxy group of phosphoenolpyruvic acid.
phosphoenolpyruvic acid : A monocarboxylic acid that is acrylic acid substituted by a phosphonooxy group at position 2. It is a metabolic intermediate in pathways like glycolysis and gluconeogenesis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yuan, F1
Brandt, NR1
Pinto, JM1
Wasserlauf, BJ1
Myerburg, RJ1
Bassett, AL1

Other Studies

1 other study available for phosphoenolpyruvate and Left Ventricular Hypertrophy

ArticleYear
Hypertrophy decreases cardiac KATP channel responsiveness to exogenous and locally generated (glycolytic) ATP.
    Journal of molecular and cellular cardiology, 1997, Volume: 29, Issue:10

    Topics: Adenosine Triphosphate; Animals; Cats; Cell Membrane Permeability; Female; Glycolysis; Hypertrophy,

1997